Literature DB >> 12681293

Id proteins in epithelial cells.

Jean-Philippe Coppé1, Andrew P Smith, Pierre-Yves Desprez.   

Abstract

Id helix-loop-helix (Id HLH) proteins are negative regulators of basic HLH transcription factors. They are expressed during embryonic development and are important for the regulation of cell phenotypes in adults. They participate in the molecular networks controlling cell growth, differentiation, and carcinogenesis, through specific basic HLH and non-basic HLH protein interactions. Recent in vitro and in vivo data implicate Id HLH as important orchestrating proteins of homeostasis in glandular and protective epithelia. In particular, Id proteins have been reported to be involved in cell behavior in epidermis, respiratory system, digestive tract, pancreas, liver, thyroid, urinary system, prostate, testis, endometrium, cervix, ovary, and mammary gland. The purpose of this review is to summarize the evidence implicating Id proteins in the regulation of mammalian epithelial cell phenotypes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12681293     DOI: 10.1016/s0014-4827(03)00014-4

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  23 in total

Review 1.  Helix-loop-helix proteins in mammary gland development and breast cancer.

Authors:  Pierre-Yves Desprez; Tomoki Sumida; Jean-Philippe Coppé
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

2.  Snail interacts with Id2 in the regulation of TNF-α-induced cancer cell invasion and migration in OSCC.

Authors:  Jing-Ping Zhou; Zhen-Lin Gao; Mei-Ling Zhou; Meng-Ying He; Xiao-Hui Xu; De-Tao Tao; Cong-Chong Yang; Lai-Kui Liu
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

3.  Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis.

Authors:  Sean D McAllister; Ryuichi Murase; Rigel T Christian; Darryl Lau; Anne J Zielinski; Juanita Allison; Carolina Almanza; Arash Pakdel; Jasmine Lee; Chandani Limbad; Yong Liu; Robert J Debs; Dan H Moore; Pierre-Yves Desprez
Journal:  Breast Cancer Res Treat       Date:  2010-09-22       Impact factor: 4.872

Review 4.  Transcriptional control of the cell cycle in mammary gland development and tumorigenesis.

Authors:  Ricardo D Coletta; Paul Jedlicka; Arthur Gutierrez-Hartmann; Heide L Ford
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

5.  Id-1 is a key transcriptional regulator of glioblastoma aggressiveness and a novel therapeutic target.

Authors:  Liliana Soroceanu; Ryuichi Murase; Chandani Limbad; Eric Singer; Juanita Allison; Isabel Adrados; Rumi Kawamura; Arash Pakdel; Yayoi Fukuyo; Daniel Nguyen; Sabeena Khan; Robert Arauz; Garret L Yount; Dan H Moore; Pierre-Yves Desprez; Sean D McAllister
Journal:  Cancer Res       Date:  2012-12-13       Impact factor: 12.701

6.  Inhibition of Id proteins by a peptide aptamer induces cell-cycle arrest and apoptosis in ovarian cancer cells.

Authors:  D S Mern; J Hasskarl; B Burwinkel
Journal:  Br J Cancer       Date:  2010-09-14       Impact factor: 7.640

7.  Suppression of inhibitor of differentiation 2, a target of mutant p53, is required for gain-of-function mutations.

Authors:  Wensheng Yan; Gang Liu; Ariane Scoumanne; Xinbin Chen
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

8.  Latent TGFbeta1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder.

Authors:  Allen G Li; Donna Wang; Xin-Hua Feng; Xiao-Jing Wang
Journal:  EMBO J       Date:  2004-04-01       Impact factor: 11.598

9.  Id2, Id3 and Id4 overcome a Smad7-mediated block in tumorigenesis, generating TGF-β-independent melanoma.

Authors:  Kyle A DiVito; Cynthia M Simbulan-Rosenthal; You-Shin Chen; Valerie A Trabosh; Dean S Rosenthal
Journal:  Carcinogenesis       Date:  2013-12-16       Impact factor: 4.944

10.  Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.

Authors:  Jason P W Carey; Ananthi J Asirvatham; Oliver Galm; Tandeih A Ghogomu; Jaideep Chaudhary
Journal:  BMC Cancer       Date:  2009-06-07       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.